Showing results (41-50 of 112) with videos related to
Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2007
Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapyTakeya Sato, Anton Neschadim, Manfred Konrad, et al.Blood|September 20, 2002
Interleukin 7 worsens graft-versus-host diseaseManoj L Sinha, Terry J Fry, Daniel H Fowler, et al.Blood|July 12, 2003
CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effectsUnsu Jung, Jason E Foley, Andreas A Erdmann, et al.Blood|March 9, 2007
Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine productionJames T Snyder, Jijia Shen, Hooman Azmi, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
Double Imprinted Nanoparticles for Sequential Membrane-to-Nuclear Drug DeliveryPankaj Singla, Thomas Broughton, Mark V Sullivan, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2012
Cell fate control gene therapy based on engineered variants of human deoxycytidine kinaseAnton Neschadim, James C M Wang, Takeya Sato, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2006
Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapyUnsu Jung, Jason E Foley, Andreas A Erdmann, et al.Journal of Translational Medicine|September 17, 2014
Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapiesDavid F Stroncek, Vicki Fellowes, Chauha Pham, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantationSeth M Pollack, Seth M Steinberg, Jeanne Odom, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2007
Multiple reduced-intensity conditioning regimens facilitate correction of Fabry mice after transplantation of transduced cellsSheng-Ben Liang, Makoto Yoshimitsu, Armando Poeppl, et al.Pageof 12